Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia

Bio2RDF uri

Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia

http://bio2rdf.org/clinicaltrials:NCT01859312

Bio2RDF identifier

NCT01859312

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT01859312

http://www.w3.org/2001/XMLSchema#string

brief summary [clinicaltrials_vocabulary:brief-summary]

Background: - ...... joining the study

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Percent of patients with 17-OH Progesterone levels equal or below 1,200 ng/dL at 8 a.m. 6 mos [clinicaltrials_resource:60e47a0a4f3a3ba17c8a6dde9c06a6bc]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Percent of patients with 17-OH Progesterone levels equal or below 1,200 ng/dL at 8 a.m. 6 mos [clinicaltrials_resource:400d89838c8daf62867a00ae2f9df444]

Percent of patients with 17-OH Progesterone levels equal or below 1,200 ng/dL at 8 a.m. 6 mos [clinicaltrials_resource:621b64e710ff0a33683d58a04e080b06]

Percent of patients with 17-OH Progesterone levels equal or below 1,200 ng/dL at 8 a.m. 6 mos [clinicaltrials_resource:6fb410ac570faf0ce07d4c6667020869]

Percent of patients with 17-OH Progesterone levels equal or below 1,200 ng/dL at 8 a.m. 6 mos [clinicaltrials_resource:c41fbe4cc9be69b0c7939c758532f9b6]

Percent of patients with 17-OH Progesterone levels equal or below 1,200 ng/dL at 8 a.m. 6 mos [clinicaltrials_resource:e546031742dc7cedefecef255fd7ae6d]

Percent of patients with 17-OH Progesterone levels equal or below 1,200 ng/dL at 8 a.m. 6 mos [clinicaltrials_resource:fdc3ce075891a9ecea8549a5a1474ab2]

collaborator [clinicaltrials_vocabulary:collaborator]

National Institutes of Health Clinical Center (CC) [clinicaltrials_resource:007a75579f26d0622489b79170d20561]

completion date [clinicaltrials_vocabulary:completion-date]

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

condition [clinicaltrials_vocabulary:condition]

Excess Androgen [clinicaltrials_resource:870e189f97af595147978b6dc748ed6d]

Adrenal Insufficiency [clinicaltrials_resource:a5180ddbcfc404d559cc5c6efed3d992]

Congenital Adrenal Hyperplasia (CAH) [clinicaltrials_resource:f5cbf260b4a14398a7cd3d8bf05b0ae0]

condition browse [clinicaltrials_vocabulary:condition-browse]

Adrenocortical Hyperfunction [clinicaltrials_resource:494bbff413c01e6477cd210cea9fdbd9]

Adrenal Insufficiency [clinicaltrials_resource:a5180ddbcfc404d559cc5c6efed3d992]

Hyperandrogenism [clinicaltrials_resource:b89c53623ab5d5195171687c7e28fbe2]

Hyperplasia [clinicaltrials_resource:c10356237d759f01fa87cc5547e87805]

Adrenal Hyperplasia, Congenital [clinicaltrials_resource:d11eef12c78b8562ce76b1e539b5d586]

Adrenogenital Syndrome [clinicaltrials_resource:ecdb43fb7aaa6695c9eef767248b3b7b]

condition mesh [clinicaltrials_vocabulary:condition-mesh]

Adrenocortical Hyperfunction [clinicaltrials_resource:494bbff413c01e6477cd210cea9fdbd9]

Adrenal Insufficiency [clinicaltrials_resource:a5180ddbcfc404d559cc5c6efed3d992]

Hyperandrogenism [clinicaltrials_resource:b89c53623ab5d5195171687c7e28fbe2]

Hyperplasia [clinicaltrials_resource:c10356237d759f01fa87cc5547e87805]

Adrenal Hyperplasia, Congenital [clinicaltrials_resource:d11eef12c78b8562ce76b1e539b5d586]

Adrenogenital Syndrome [clinicaltrials_resource:ecdb43fb7aaa6695c9eef767248b3b7b]

country [clinicaltrials_vocabulary:country]

United States [clinicaltrials_resource:f253efe302d32ab264a76e0ce65be769]

detailed description [clinicaltrials_vocabulary:detailed-description]

Congenital adrenal hype ...... ture pediatric studies.

http://www.w3.org/2001/XMLSchema#string

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT01859312 [clinicaltrials_resource:c8dd6ca241c5dddfffba4d6c049a896d]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2013-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

Insulin pump (Medtronic) [clinicaltrials_resource:d0a5e23963f5efeaca725f9e3b34bd9e]

Hydrocortisone (Solucortef) [clinicaltrials_resource:fb81956c3ae9f43a699b2c0bfb084b7b]

intervention browse [clinicaltrials_vocabulary:intervention-browse]

Hydrocortisone [clinicaltrials_resource:071ea78538702d45e31cc8777513a9f1]

Hydrocortisone-17-butyrate [clinicaltrials_resource:5b3d5383e1e32600a3554815c054bcde]

Hydrocortisone acetate [clinicaltrials_resource:9f5a37caf0d1d575ba89b0d6dbb27f85]

Cortisol succinate [clinicaltrials_resource:ad086fd49baca3d6b3e93cefeade1953]

Hydrocortisone 17-butyrate 21-propionate [clinicaltrials_resource:e5d2eae24d8e5260332ebc40a1dc893e]

is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]

http://www.w3.org/2001/XMLSchema#string

keyword [clinicaltrials_vocabulary:keyword]

Adrenal Insufficiency

http://www.w3.org/2001/XMLSchema#string

Adrenal

http://www.w3.org/2001/XMLSchema#string

Congenital Adrenal Hyperplasia (CAH)

http://www.w3.org/2001/XMLSchema#string

Glucocorticoids

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2015-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

National Institutes of Health Clinical Center (CC) [clinicaltrials_resource:007a75579f26d0622489b79170d20561]

link [clinicaltrials_vocabulary:link]

NIH Clinical Center Detailed Web Page [clinicaltrials_resource:3a549ff34467cfb240de333208b1aa49]

location [clinicaltrials_vocabulary:location]

National Institutes of Health Clinical Center, 9000 Rockville Pike [clinicaltrials_resource:52d85572c5d4aa0faa2049f3662b444e]

nct id [clinicaltrials_vocabulary:nct-id]

NCT01859312

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

http://www.w3.org/2001/XMLSchema#integer

official title [clinicaltrials_vocabulary:official-title]

A Pilot Study Assessing the Us ...... Congenital Adrenal Hyperplasia

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

130.121

http://www.w3.org/2001/XMLSchema#integer

overall contact [clinicaltrials_vocabulary:overall-contact]

Deborah P Merke, M.D. [clinicaltrials_resource:db051e35e6ada2c39e7ed38bd83b7ead]

overall official [clinicaltrials_vocabulary:overall-official]

Deborah P Merke, M.D. [clinicaltrials_resource:fac6410f0df00e02d1a872236a0a9a1e]

overall status [clinicaltrials_vocabulary:overall-status]

Recruiting [clinicaltrials_resource:5231dee7156b84b0d1854de1a18dd169]

oversight [clinicaltrials_vocabulary:oversight]

United States: Federal Government [clinicaltrials_resource:15a952dd0198445f4ddd5909936bc0e7]

phase [clinicaltrials_vocabulary:phase]

Phase 1/Phase 2 [clinicaltrials_resource:72d8d9eabd48f679d5dffa41c4dd93f7]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

reference [clinicaltrials_vocabulary:reference]

19223520 [pubmed:19223520]

20719839 [pubmed:20719839]

22990093 [pubmed:22990093]

responsible party [clinicaltrials_vocabulary:responsible-party]

[clinicaltrials_resource:dbd41868ee618d3e64daa1adf8c3a8a0]

secondary id [clinicaltrials_vocabulary:secondary-id]

13-CH-0121

http://www.w3.org/2001/XMLSchema#string

source [clinicaltrials_vocabulary:source]

National Institutes of Health Clinical Center (CC) [clinicaltrials_resource:007a75579f26d0622489b79170d20561]

start date [clinicaltrials_vocabulary:start-date]

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT01859312 study design [clinicaltrials_resource:12111183e0c16e1c317ac7e9b7da60d9]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT01859312

verification date [clinicaltrials_vocabulary:verification-date]

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT01859312

http://www.w3.org/2001/XMLSchema#string

title

Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia

@en